Tecentriq

5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Roche hits FDA delay with subcutaneous version of Tecentriq amid manufacturing process changes
Fierce Pharma
Thu, 09/7/23 - 10:53 pm
Roche
FDA
Tecentriq
Halozyme
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
ASCO: Merck's Keytruda trips in EGFR lung cancer as Roche's Tecentriq fails in kidney cancer
Fierce Pharma
Tue, 06/6/23 - 04:19 pm
ASCO 2023
Merck
Keytruda
EGFR lung cancer
Roche
Tecentriq
kidney cancer
Roche nixes Tecentriq trial in early breast cancer, but it's 'still in the game' in key lung cancer use: exec
Fierce Pharma
Wed, 04/26/23 - 10:12 am
Roche
Tecentriq
breast cancer
Teresa Graham
Pharma CEOs
Genentech reveals positive results from cancer combo therapy trial
Clinical Trials Arena
Mon, 04/17/23 - 11:24 am
Genentech
Tecentriq
Avastin
liver cancer
hepatocellular carcinoma
Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure
BioSpace
Fri, 03/3/23 - 12:01 pm
Roche
Exelixis
renal cell carcinoma
Tecentriq
Cabometyx
clinical trials
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
Roche’s Tecentriq to be filed for early-stage liver cancer
Pharmaphorum
Thu, 01/19/23 - 09:41 am
Roche
Tecentriq
Avastin
clinical trials
liver cancer
Roche wins earlier-than-expected approval for blockbuster Tecentriq in rare soft tissue cancer
Endpoints
Tue, 12/13/22 - 11:50 pm
Roche
Tecentriq
FDA
soft tissue cancer
Combo of Roche's Tecentriq and Exelixis' Cabometyx fails another trial, this time in lung cancer
Fierce Pharma
Sun, 12/11/22 - 01:20 pm
Roche
Tecentriq
Exelixis
Cabometyx
clinical trials
non small cell lung cancer
Exelixis drug fails PhIII lung cancer trial with Cabometyx and Tecentriq combo
Endpoints
Fri, 12/9/22 - 10:39 am
Exelixis
Cabometyx
Tecentriq
metastatic non-small cell lung cancer
clinical trials
Roche, having shared data with regulators, unwraps results of subcutaneous Tecentriq phase 3 trial
Fierce Pharma
Thu, 12/1/22 - 10:55 am
Roche
Tecentriq
clinical trials
non-small cell lung cancer
Roche Withdraws Tecentric for Bladder Cancer Indication
BioSpace
Tue, 11/29/22 - 11:06 am
Roche
Genentech
bladder cancer
metastatic bladder cancer
Tecentriq
Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data
Fierce Pharma
Tue, 08/2/22 - 10:54 am
Roche
Pfizer
Merck
Tecentriq
clinical trials
cancer
checkpoint inhibitors
Roche Sees More Growth Opportunities for Phesgo, Tecentriq; Still Optimistic on Tiragolumab
Precision Oncology News
Fri, 07/22/22 - 10:14 am
Roche
earnings
oncology
Phesgo
Tecentriq
Merck fights back against Roche in adjuvant lung cancer therapy
Pharmaforum
Fri, 03/18/22 - 10:54 am
Merck
Keytruda
non-small cell lung cancer
clinical trials
Roche
Tecentriq
Chasing Roche, Merck unveils adjuvant lung cancer data for Keytruda
Pharmaforum
Tue, 01/11/22 - 11:28 am
Merck
Roche
Keytruda
clinical trials
non-small cell lung cancer
Tecentriq
Roche builds case for TIGIT combo in untreated lung cancer
Pharmaforum
Fri, 12/10/21 - 10:50 am
Roche
anti-TIGIT
tiragolumab
Tecentriq
lung cancer

Pages